Statin Selection in the Elderly

Slides:



Advertisements
Similar presentations
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
Advertisements

Pravastatin in Elderly Individuals at Risk of Vascular Disease
The Latest Lipid Guidelines:
Recommendation of NLA Expert Panel on Treatment With PCSK9 Inhibitors
PCSK9 Inhibitors and Cardiovascular Outcomes Trials
Diabetic Dyslipidemia in Practice
Updates and Perspectives in Diabetic Dyslipidemia
PCSK9 Inhibitors Post-CVOTs
Optimizing Statin Therapy
An Endocrinology Clinic in Dyslipidemia
Statin Selection Aimed to Reduce New-Onset DM Risk:
Diabetes and Dyslipidemia
Tailoring Statin Therapy in Women
Challenging Statin Intolerance: Back to Basics
Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?
Select Topics in Cardiovascular Medicine
American Heart Association Scientific Sessions
Obesity and Dyslipidemia: How Would You Treat?
Advances in Dyslipidemia: What Have We Learned From ACC 2017
Statins and the Elderly Patient
Patient Presentation. Dyslipidemia Management Beyond Statins: Will PCSK9 Inhibition Trigger a Revolution?
Beyond Statin Therapy.
LDL-C Goals. The Patient With Difficult-to-Treat Hypercholesterolemia: Is Everything Under Control?
Goals. The Truth About Statins: High vs Moderate Dose for Secondary Prevention of CAD.
Statins and New-Onset Diabetes REAL Updates and Clinical Implications
Statin Class in Session
Diabetes Increases Risk of CVD
Assessing the State of Statin Therapy
An Update on PCSK9 Inhibitors
Evaluating LDL-C Recommendations
New Pathways in Lipid Care
What's New in Dyslipidemia?
Statins and Glucose Metabolism: Are All Agents Alike?
Statin Class in Session
PCP View: ACC/AHA Guidelines: Role of Moderate Intensity Statins
Personalizing Statin Therapy in Patients With HIV
A Journal Club on Lipid Management:
PCSK9 Inhibitors and Cardiovascular Outcomes
Overview. 5 Things You Need to Know About Statin Selection in Patients With HIV Infection.
Improving Appropriate Access to PCSK9 Inhibitors
Statins and HIV:.
New LDL-C Lipid Targets
A PCP's Guide to Dyslipidemia
Learning Objectives Metabolic Abnormalities Associated With T2D.
Lipid Clinic Challenge
Clinicians' Corner in Dyslipidemia
Updates in Cardiovascular Medicine
WHAT’S NEW WITH THE TREATMENTS FOR HIGH-RISK DYSLIPIDEMIA?
Definition of Elderly. Advanced Age and CV Risk: To Start or Not to Start a Statin in Older Patients?
Advances in Hypertriglyceridemia Treatment
Addressing Access to PCSK9 Inhibitors: Tips and Tools for Practicing Clinicians.
Statins, Obesity, and Hyperlipidemia
Glucose Management and Statin Therapy
LDL Cholesterol.
How to Optimize Cholesterol Management in High-Risk CV Patients
Latest Lipid Guidelines in Perspective
Goals. The Truth About Statins: High vs Moderate Dose for Secondary Prevention of CAD.
Reducing Risk for CV Outcomes
New Lipid-Lowering Guidelines
Lipid Updates From Spring 2019
An Update on PCSK9 Inhibitors
Statins and Glucose Metabolism: An Endocrinology Perspective
Glucose Management and Statin Therapy
PCSK9 Inhibitors and Statin Intolerance
Updates on Dyslipidemia
Statin Selection in Patients With Pre-Diabetes: Case Considerations
Lipids, the Heart, and the Kidney
Risk Stratification of Patients With Type 2 Diabetes: An Interpretation of the Latest Treatment Guidelines.
PCSK9 Inhibitors and Real-World Evidence
Shared-Decision Making in Dyslipidemia
Presentation transcript:

Statin Selection in the Elderly

The Elderly

Old Age Equals Increased Risk for CVD

Clinical Practice Decisions

Age as a Risk Factor

Considerations in Elderly Population

NLA Recommendations in Older Patients

Other Lipid-Lowering Options to Consider for the Elderly: Ezetimibe and PCSK9 Inhibitors

Calcium Scores for the Reclassification of Coronary Events

Statins Reduce Risk for Stroke in Elderly Population

Statin Use Associated With Significantly Lower Risk for Mortality in Elderly Population

2013 ACC/AHA Guidelines for Lipid Management in Older Patients

Cardiac Care for Elderly Population Purposefully Manage Pharmacologic Regimen

Conversing With Your Patients

PROSPER Pravastatin in Elderly Population

Pitavastatin Extension Study

Human CYP450 Isoenzymes Known to Oxidize Clinically Used Drugs

Metabolic Syndrome

Risk of Developing New-Onset Diabetes Meta-Analysis of Placebo-Controlled Statin Trials

REAL-CAD

FOURIER Outcomes

Cognitive Dysfunction

Treatment Approaches

Lifestyle Modifications in Elderly Population

IMPROVE-IT

Conclusion

Abbreviations

Abbreviations (cont)

Abbreviations (cont)